Chief scientist OKs new projects

Of 21 industrial R&D projects, 3 are in software development, 4 in electronics, 2 in medical equipment, 3 in developing new medicines and 5 in biotechnology.

September 28, 2007 01:48
test tubes science 88

test tube science 88. (photo credit: )


Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief


Nine new incubator companies and 21 industrial research and development programs were approved this week by the Industry, Trade and Labor Ministry's Office of the Chief Scientist for a total investment of $84.2 million. Of the 21 industrial R&D projects, three are in software development, four are in electronics, two are focused on medical equipment, three are concentrated on developing new medicines and five will be in the biotechnology sector at a total investment of NIS 68.2m. "The research commission in the Chief Scientist's Office has now approved funding for more than 100 R&D projects since we established the program at the end of 2005," noted chief scientist Dr. Eli Opper upon the announcement. The office also approved four international R&D projects, with Switzerland, France and Germany. Meanwhile, the Chief Scientist's Incubators Program Department approved the nine new programs in that area at an investment of NIS 16m. Included among the projects is a project at Xenia Venture Capital Ltd. for automatically locating and removing Internet content that harms public sensibilities and a project at Iris Ventures (formerly Am-Shav Technological Applied Development Center) in Sde Boker, to develop an information protection system for files, which also monitors the files and reports on them.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection